Berber M. Mol

886 total citations
11 papers, 326 citations indexed

About

Berber M. Mol is a scholar working on Oncology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Berber M. Mol has authored 11 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Ophthalmology and 4 papers in Molecular Biology. Recurrent topics in Berber M. Mol's work include Cancer-related Molecular Pathways (6 papers), Ocular Oncology and Treatments (6 papers) and Cancer Genomics and Diagnostics (3 papers). Berber M. Mol is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Ocular Oncology and Treatments (6 papers) and Cancer Genomics and Diagnostics (3 papers). Berber M. Mol collaborates with scholars based in Netherlands, Greece and South Africa. Berber M. Mol's co-authors include Hanne Meijers‐Heijboer, Josephine C. Dorsman, Annette C. Moll, Jacqueline Cloos, Hein te Riele, Gertjan J.L. Kaspers, Annemarie H. van der Hout, Irsan Kooi, Charlotte J. Dommering and Maarten P.G. Massink and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular Cancer.

In The Last Decade

Berber M. Mol

10 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berber M. Mol Netherlands 8 201 197 128 68 62 11 326
Oliver Surriga United States 6 112 0.6× 101 0.5× 146 1.1× 20 0.3× 100 1.6× 10 303
Jessica Sher United States 6 190 0.9× 91 0.5× 192 1.5× 38 0.6× 89 1.4× 8 333
María Gomez‐Caraballo United States 8 123 0.6× 185 0.9× 128 1.0× 60 0.9× 34 0.5× 15 392
Britta Bia United Kingdom 8 125 0.6× 147 0.7× 285 2.2× 22 0.3× 14 0.2× 10 378
P Esser Germany 13 294 1.5× 46 0.2× 177 1.4× 29 0.4× 44 0.7× 31 463
Harutyun Melkonyan Germany 13 97 0.5× 26 0.1× 232 1.8× 50 0.7× 133 2.1× 20 363
Naoyasu Umeda United States 10 254 1.3× 30 0.2× 264 2.1× 33 0.5× 27 0.4× 16 450
Nagasamy Soumittra India 14 236 1.2× 33 0.2× 336 2.6× 38 0.6× 20 0.3× 27 490
Ming Ni China 6 132 0.7× 15 0.1× 128 1.0× 87 1.3× 115 1.9× 15 342
María José Gamundi Spain 13 92 0.5× 58 0.3× 234 1.8× 47 0.7× 12 0.2× 19 365

Countries citing papers authored by Berber M. Mol

Since Specialization
Citations

This map shows the geographic impact of Berber M. Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berber M. Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berber M. Mol more than expected).

Fields of papers citing papers by Berber M. Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berber M. Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berber M. Mol. The network helps show where Berber M. Mol may publish in the future.

Co-authorship network of co-authors of Berber M. Mol

This figure shows the co-authorship network connecting the top 25 collaborators of Berber M. Mol. A scholar is included among the top collaborators of Berber M. Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berber M. Mol. Berber M. Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kooi, Irsan, Berber M. Mol, Maarten P.G. Massink, et al.. (2016). Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Scientific Reports. 6(1). 25264–25264. 74 indexed citations
2.
Kooi, Irsan, Berber M. Mol, Maarten P.G. Massink, et al.. (2016). A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression. PLoS ONE. 11(4). e0153323–e0153323. 56 indexed citations
3.
Kooi, Irsan, Saskia E. van Mil, David MacPherson, et al.. (2016). Genomic landscape of retinoblastoma in Rb−/−p130−/− mice resembles human retinoblastoma. Genes Chromosomes and Cancer. 56(3). 231–242. 5 indexed citations
4.
Kooi, Irsan, Berber M. Mol, Annette C. Moll, et al.. (2015). Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine. 2(7). 660–670. 49 indexed citations
5.
Mol, Berber M., Irsan Kooi, Maarten P.G. Massink, et al.. (2014). Coregulation of FANCA and BRCA1 in human cells. SpringerPlus. 3(1). 381–381. 5 indexed citations
6.
Dommering, Charlotte J., Berber M. Mol, Annette C. Moll, et al.. (2014). RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients. Journal of Medical Genetics. 51(6). 366–374. 63 indexed citations
7.
Mol, Berber M., Maarten P.G. Massink, Annemarie H. van der Hout, et al.. (2013). High resolution SNP array profiling identifies variability in retinoblastoma genome stability. Genes Chromosomes and Cancer. 53(1). 1–14. 21 indexed citations
8.
Arranz, Alicia, Maria Venihaki, Berber M. Mol, et al.. (2010). The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. Molecular Cancer. 9(1). 261–261. 21 indexed citations
9.
Arranz, Alicia, Ariadne Androulidaki, Berber M. Mol, et al.. (2010). Intravital spectral imaging as a tool for accurate measurement of vascularization in mice. PubMed. 2(1). 22–22.
10.
Moreno, Marı́a, Berber M. Mol, Silvia von Mensdorff‐Pouilly, et al.. (2009). Differential Indirect Activation of Human Invariant Natural Killer T Cells by Toll-Like Receptor Agonists. Immunotherapy. 1(4). 557–570. 9 indexed citations
11.
Moreno, Marı́a, Berber M. Mol, Silvia von Mensdorff‐Pouilly, et al.. (2008). Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). Cancer Letters. 272(1). 70–76. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026